XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance (in shares) at Dec. 31, 2022 237,166,625        
Beginning balance at Dec. 31, 2022 $ 2,372 $ 1,259,527 $ (1,040) $ (655,382) $ 605,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Non-cash stock-based compensation   12,752     $ 12,752
Stock-based awards and related share issuances, net ( in shares) 3,086,082        
Stock-based awards and related share issuances, net $ 31 (31)      
Repurchase of common stock (in Shares)         0
Other comprehensive income     $ 1,040   $ 1,040
Net loss       (47,738) (47,738)
Ending balance (in shares) at Sep. 30, 2023 240,252,707        
Ending balance at Sep. 30, 2023 $ 2,403 1,272,248   (703,120) 571,531
Beginning balance (in shares) at Jun. 30, 2023 237,647,431        
Beginning balance at Jun. 30, 2023 $ 2,377 1,268,142   (687,420) 583,099
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Non-cash stock-based compensation   4,132     4,132
Stock-based awards and related share issuances, net ( in shares) 2,605,276        
Stock-based awards and related share issuances, net $ 26 (26)      
Net loss       (15,700) (15,700)
Ending balance (in shares) at Sep. 30, 2023 240,252,707        
Ending balance at Sep. 30, 2023 $ 2,403 1,272,248   (703,120) $ 571,531
Beginning balance (in shares) at Dec. 31, 2023 240,499,833       240,499,833
Beginning balance at Dec. 31, 2023 $ 2,405 1,276,581   (721,597) $ 557,389
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Non-cash stock-based compensation   12,485     12,485
Stock-based awards and related share issuances, net ( in shares) 6,015,823        
Stock-based awards and related share issuances, net $ 60 481     $ 541
Repurchase of common stock (in Shares) (7,190,006)       7,200,000
Repurchase of common stock $ (72) (4,638)     $ (4,710)
Issuance of common stock upon exercise of warrants (in shares) 81,798        
Issuance of common stock upon exercise of warrants $ 1 48     49
Net loss       (61,033) $ (61,033)
Ending balance (in shares) at Sep. 30, 2024 239,407,448       239,407,448
Ending balance at Sep. 30, 2024 $ 2,394 1,284,957   (782,630) $ 504,721
Beginning balance (in shares) at Jun. 30, 2024 240,565,240        
Beginning balance at Jun. 30, 2024 $ 2,406 1,281,810   (761,474) 522,742
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Non-cash stock-based compensation   3,786     3,786
Stock-based awards and related share issuances, net ( in shares) (145,097)        
Stock-based awards and related share issuances, net $ (2) (52)     $ (54)
Repurchase of common stock (in Shares) (1,094,493)       1,100,000
Repurchase of common stock $ (11) (635)     $ (646)
Issuance of common stock upon exercise of warrants (in shares) 81,798        
Issuance of common stock upon exercise of warrants $ 1 48     49
Net loss       (21,156) $ (21,156)
Ending balance (in shares) at Sep. 30, 2024 239,407,448       239,407,448
Ending balance at Sep. 30, 2024 $ 2,394 $ 1,284,957   $ (782,630) $ 504,721